The NYC Biotechnology Tax Credit is designed to support investors and owners of qualified biotechnology companies. This tax credit can be applied against business corporation tax, general corporation tax, and unincorporated business tax. It covers certain expenses for businesses in the biotechnology field within New York City.
The aim of the Biotechnology Tax Credit is to enhance the success of small life-science firms by helping offset high startup costs, including research and development, incubator space, and clinical development processes. This tax incentive encourages job creation and supports related industries.
To qualify for the Biotechnology Tax Credit, a company must satisfy each of the following six criteria:
Submit your application by January 15 following the calendar year for which you would like to claim the credit. If this date falls on a weekend or a holiday, the deadline extends to the next business day. Upon approval, the Department of Finance will issue a Certificate of Eligibility. Applications for 2024 must be filed by January 15, 2025.
You must register to file a business tax return at www.nyc.gov/eservices before you can file a biotechnology credit application online.
Once you have registered, you will be able to log in. From your account panel, click “More Requests,” then select “Biotechnology Credit Application” within the Business Credit Applications section.
Please note that if you are included as a subsidiary in a combined group filing a general corporation tax return, business corporation tax return, or other type of return, you must register in e-Services with your own EIN in order to apply for the Biotechnology credit.
The tax credit is valid for taxable years from January 1, 2023, to December 31, 2025. It can be claimed for a maximum of three consecutive tax years.
The Biotechnology Tax Credit can be refunded or applied against the next year's tax if it exceeds the current year's tax liability. For combined group filers, the credit is computed separately and applied against the combined tax. Visit our FAQs for details on emerging technologies and qualifying expenses.
Biotechnology involves scientific manipulation of living organisms for products that improve life and health and the associated scientific research, pharmacological, mechanical, and computational applications and services connected with these improvements.
Emerging technologies include advanced materials, defense technologies, electronic and photonic devices, information and communication technologies, and remanufacturing technologies. More specifically:
Qualifying expenses include property purchases, research, and employee training, with specific percentages and limits applied.